Papers - SAITO MANABU
-
Dose-dependent interaction of paroxetine with risperidone in schizophrenic patients
M Saito, N Yasui-Furukori, T Nakagami, H Furukori, S Kaneko
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY 25 ( 6 ) 527 - 532 2005.12
-
Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: in vivo evidence of involvement of P-glycoprotein in risperidone disposition.（共著）
Nakagami T, Yasui-Furukori N, Saito M, Tateishi T, Kaneo S.
Clinical Pharmacology and Therapeutics 78 ( 1 ) 43 - 50 2005.7
-
Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: In vivo evidence of involvement of P-glycoprotein in risperidone disposition
T Nakagami, N Yasui-Furukori, M Saito, T Tateishi, S Kaneo
CLINICAL PHARMACOLOGY & THERAPEUTICS 78 ( 1 ) 43 - 51 2005.7
-
Clinical pharmacogenetics in the treatment of schizophrenia
Manabu Saito, Norio Yasui-Furukori, Sunao Kaneko
Japanese Journal of Neuropsychopharmacology 25 ( 3 ) 129 - 135 2005.7
-
Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes
M Saito, N Yasui-Furukori, T Uno, T Takahata, K Sugawara, A Munakata, T Tateishi
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 59 ( 3 ) 302 - 309 2005.3
-
Thioridazine inhibits risperidone metabolism: a clinically relevant drug interaction.(共著)
Nakagami T, Yasui-Furukori N, Saito M, Mihara K, De Vries R, Kondo T, Kaneko S.
Journal of Clinical Psychopharmacology 25 ( 1 ) 89 - 91 2005.2
-
Thioridazine inhibits risperidone metabolism - A clinically relevant drug interaction
T Nakagami, N Yasui-Furukori, M Saito, K Mihara, R De Vries, T Kondo, S Kaneko
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY 25 ( 1 ) 89 - 91 2005.2
-
Steady-state pharmacokinetics of a new antipsychotic agent perospirone and its active metabolite, and its relationship with prolactin response.(共著)
Yasui-Furukori N, Furukori H, Nakagami T, Saito M, Inoue Y, Kaneko S, Tateishi T.
Therapeutic Drug Monitoring 26 ( 4 ) 361 - 365 2004.8
-
Steady-state pharmacokinetics of a new antipsychotic agent perospirone and its active metabolite, and its relationship with prolactin response
N Yasui-Furukori, H Furukori, T Nakagami, M Saito, Y Inoue, S Kaneko, T Tateishi
THERAPEUTIC DRUG MONITORING 26 ( 4 ) 361 - 365 2004.8
-
Establishment of new cloned enzyme donor immunoassays (CEDIA) for haloperidol and bromperidol.(共著)
Yasui-Furukori N, Saito M, Furukori H, Inoue Y, Someya T, Kaneko S, Tateishi T.
Therapeutic Drug Monitoring 26 ( 3 ) 336 - 341 2004.6
-
Establishment of new cloned enzyme donor immunoassays (CEDIA((R))) for haloperidol and bromperidol
N Yasui-Furukori, M Saito, H Furukori, Y Inoue, T Someya, S Kaneko, T Tateishi
THERAPEUTIC DRUG MONITORING 26 ( 3 ) 336 - 341 2004.6
-
Poor reliability of therapeutic drug monitoring data for haloperidol and bromperidol using enzyme immunoassay.（共著）
Yasui-Furukori N, Furukori H, Saito M, Inoue Y, Kaneko S, Tateishi T.
Therapeutic Drug Monitoring 25 ( 6 ) 709 - 714 2003.12
-
Poor reliability of therapeutic drug monitoring data for haloperidol and bromperidol using enzyme immunoassay
N Yasui-Furukori, H Furukori, M Saito, Y Inoue, S Kaneko, T Tateishi
THERAPEUTIC DRUG MONITORING 25 ( 6 ) 709 - 714 2003.12